Efficacy of saponin-based inactivated rock bream iridovirus (RBIV) vaccine in rock bream (Oplegnathus fasciatus). Issue 121 (February 2022)

• Record Type: Journal Article
• Authors: Jung, Myung-Hwa; Kole, Sajal; Jung, Sung-Ju
• Is Part Of: Fish & shellfish immunology. Issue 121(2022)
• Page Start: 12
• Page End: 22
• Publication Date: 2022-02
• Subjects: Megalocytivirus -- Rock bream iridovirus -- Saponin -- Adjuvant -- Fish vaccine -- Oplegnathus fasciatus; Fishes -- Immunology -- Periodicals; Shellfish -- Immunology -- Periodicals; Poissons -- Immunologie -- Périodiques; Crustacés -- Immunologie -- Périodiques; 571.9617
• DOI: 10.1016/j.fsi.2021.12.047
• Languages: English
• ISSNs: 1050-4648

Abstract

Abstract: Rock bream iridovirus (RBIV) causes severe mortality in rock bream ( Oplegnathus fasciatus ) for last two decades. In view of this constant threat of RBIV to the rock bream industry, we conducted the present study with the aim to develop a safe and efficient remedial measure against the virus. In this study, we evaluated the safety and potentiality of squalene, aluminium hydroxide and saponin adjuvants, singly or in combinations, which can be used for developing an efficient inactivated (IV) vaccine to protect rock bream from RBIV infection. The evaluation results demonstrated that saponin (Sa) has the required potential in enacting the antiviral immune response in the host and in providing protection against virus mediated lethality, without causing any adverted side-effects. The study further, showed that a single primary dose of Sa-adjuvanted IV vaccine can confer moderate protections in short (60.04% relative percent mortality (RPS) at 4 wpv) and medium (53.38% RPS at 8 wpv) term post RBIV challenge; whereas, the same vaccine when administered in a prime-boost strategy, it resulted enhanced 93.34% RPS post virus challenge at 4 and 8 wpv. The moderate to high survivability demonstrated by the Sa-adjuvanted IV vaccine, was substantiated by the significant ( p < 0.05) upregulation of IL-1β, Mx and PKR gene transcript. All surviving fish from the Sa-adjuvanted IV vaccine groups were strongly protected from re-infection with RBIV (1.1 × 10 7 ) at 70 days post infection (dpi). In conclusion, it can be inferred that, Sa-adjuvanted IV RBIV vaccine can be an efficient control measure to protect the rock bream aquaculture industry against the lethal RBIV virus. Highlights: Administration of saponin adjuvant-based inactivated RBIV vaccine offered significantly high protection. Boost immunization with vaccine provided significantly higher protection than one time immunization. Saponin adjuvant-based inactivated RBIV vaccine upregulated Il-1β, Mx and PKR gene expression.